Programme
Access the online programme for TAT 2020 – Targeted Anticancer Therapies!
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.
Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients.
The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.
In view of the spread of Coronavirus infections across Europe and now increasingly in France, ESMO has made the difficult but necessary decision not to proceed with the TAT Congress, due to take place 2-4 March in Paris.
Access the online programme for TAT 2020 – Targeted Anticancer Therapies!
All the resources from ESMO Targeted Anticancer Therapies Congress 2020: abstracts and abstract book are available.
Find out who are the TAT 2020 Congress Officers
Participation information for our industry partners
Get in touch with the organisers of ESMO Targeted Anticancer Therapies Congress 2020. Contact details here
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.